GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
Currently predicting for Fri, 19 Apr 2024

Trading levels for CANF

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.10 6.77 %
R2 2.07 4.83 %
R1 2.04 3.63 %
Current price: 1.97
Support S1 1.97 -0.247 %
S2 1.94 -1.45 %
S3 1.90 -3.38 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.11 6.85 %
R2 2.10 6.60 %
R1 2.06 4.57 %
Current price 1.97
Support S1 1.96 -0.508%
S2 1.95 -1.02%
S3 1.93 -2.03%

CANF Predictions History

2 years ago
JS predicted that CANF for 2022-01-18 is going $1.34 (2.29%)

2 years ago
moej726.293131 predicted that CANF for 2022-01-18 is going $1.40 (6.87%)

Rank:

4 years ago
JS predicted that CANF for 2020-01-06 is going $3.71 (5.40%)

4 years ago
esteban sanchez predicted that CANF for 2019-12-02 is going

Rank:

4 years ago
NameNotImportant predicted that CANF for 2019-05-06 is going $0.383 (-5.92%)

4 years ago
NameNotImportant predicted that CANF for 2019-05-03 is going $0.406 (-0.51%)

Click to get the best stock tips daily for free!

About Can-Fite BioPharma Ltd

Can-Fite BioPharma Ltd Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis; and Phase II clinical trial for the treatment of COVID-19. It also develops Namodenoson that is in Phase III clinical tria... CANF Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT